Potential Applications of Nanoparticles for Hyperthermia
Nenhuma Miniatura disponível
Data
2015-01-01
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Springer
Tipo
Artigo
Direito de acesso
Resumo
There is converging evidence that clinical mild temperature hyperthermia sensitizes tumors to conventional therapies as chemotherapy and radiation therapy. Coupled with an increasing understanding of the biological basis of this synergy there has been a parallel increase in the ability to achieve, maintain, measure and monitor temperature and its physiological and physical consequences. A new entrant in the arena of hyperthermia generation is nanotechnology which capitalizes on locally injected or systemically administered nanoparticles that home to tumors and are activated by extrinsic energy sources to generate heat. This chapter highlights the unique opportunities and challenges with implementing hyperthermia mediated by a variety of engineered nanoparticles for cancer therapy.
Descrição
Palavras-chave
Idioma
Inglês
Como citar
Heat Shock Protein-based Therapies. Dordrecht: Springer, v. 9, p. 197-216, 2015.